A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

NCT00295633 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

565

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Saxagliptin
DRUG: Saxagliptin
DRUG: Placebo
DRUG: pioglitazone
DRUG: rosiglitazone
DRUG: metformin

Sponsor

AstraZeneca